ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives
Open Access
- 17 July 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (7) , e931
Abstract
Background: Congenital ISG15 deficiency is a rare autoinflammatory disorder that is driven by chronically elevated systemic interferon levels and predominantly affects central nervous system and skin.Methods and results: We have developed induced pluripotent stem cell‐derived macrophages and endothelial cells as a model to study the cellular phenotype of ISG15 deficiency and identify novel treatments. ISG15–/– macrophages exhibited the expected hyperinflammatory responses, but normal phagocytic function. In addition, they displayed a multifaceted pathological phenotype featuring increased apoptosis/pyroptosis, oxidative stress, glycolysis, and acylcarnitine levels, but decreased glutamine uptake, BCAT1 expression, branched chain amino acid catabolism, oxidative phosphorylation, β‐oxidation, and NAD(P)H‐dependent oxidoreductase activity. Furthermore, expression of genes involved in mitochondrial biogenesis and respiratory chain complexes II–V was diminished in ISG15–/– cells. Defective mitochondrial respiration was restored by transduction with wild‐type ISG15, but only partially by a conjugation‐deficient variant, suggesting that some ISG15 functions in mitochondrial respiration require ISGylation to cellular targets. Treatment with itaconate, dimethyl‐itaconate, 4‐octyl‐itaconate, and the JAK1/2 inhibitor ruxolitinib ameliorated increased inflammation, propensity for cell death, and oxidative stress. Furthermore, the treatments greatly improved mitochondria‐related gene expression, BCAT1 levels, redox balance, and intracellular and extracellular ATP levels. However, efficacy differed among the compounds according to read‐out and cell type, suggesting that their effects on cellular targets are not identical. Indeed, only itaconates increased expression of anti‐oxidant genes NFE2L2, HMOX1, and GPX7, and dimethyl‐itaconate improved redox balance the most. Even though itaconate treatments normalized the elevated expression of interferon‐stimulated genes, ISG15–/– macrophages maintained their reduced susceptibility to influenza virus infection.Conclusions: These findings expand the cellular phenotype of human ISG15 deficiency and reveal the importance of ISG15 for regulating oxidative stress, branched chain amino acid metabolism, and mitochondrial function in humans. The results validate ruxolitinib as treatment for ISG15 deficiency and suggest itaconate‐based medications as additional therapeutics for this rare disorder.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst
This publication has 61 references indexed in Scilit:
- BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1Nature Medicine, 2013
- Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid productionProceedings of the National Academy of Sciences, 2013
- Role of Nrf2 in Oxidative Stress and ToxicityAnnual Review of Pharmacology and Toxicology, 2013
- Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 DeficiencyScience, 2012
- Type I interferonopathies: a novel set of inborn errors of immunityAnnals of the New York Academy of Sciences, 2011
- Caspase‐1‐induced pyroptotic cell deathImmunological Reviews, 2011
- GSK3β Promotes Apoptosis after Renal Ischemic InjuryJournal of the American Society of Nephrology, 2010
- Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling PathwaysJournal of Biological Chemistry, 2009
- MetaboliteDetector: Comprehensive Analysis Tool for Targeted and Nontargeted GC/MS Based Metabolome AnalysisAnalytical Chemistry, 2009
- Proteomic identification of proteins conjugated to ISG15 in mouse and human cellsBiochemical and Biophysical Research Communications, 2005